Do you or a loved one live with breast cancer? It’s common to feel overwhelmed, but you don’t have to go through this alone. Learn more about the disease in our Condition Guide, created with expertise from our patient community.

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19 [Nov 3, 2022] Ziad Bakouny, MD, MSc et al. Toni Choueiri, MD Trisha Wise-Draper, MD, PhD COVID-19 and Cancer Consortium (CCC19) Registry JAMA Oncology jamanetwork.com/journals/jamao… #COVID19nCancer #CCC19 #IDonc #ImmunoOnc #NCT04354701

Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a RCT [Dec 29, 2022] Claudia Denkinger et al HT Michael Joyner Nature Cancer #COVID19 CP #COVID19 nCancer #IDonc #COVID19
nature.com/articles/s4301…

Crowdsourcing a crisis response for COVID-19 in oncology [Apr 21, 2020] Aakash Desai, MD, MPH @hemoncwarner Dr. Nicole Kuderer 🌎🇺🇸🇪🇺🇺🇦💛💙🌏 Mike Thompson, MD, PhD, FASCO Dear Dr. Researcher, PhD Gary Lyman 🇺🇸🇪🇺🇺🇦💛💙 gilberto lopes Nature Cancer ow.ly/wuyD30qzDyS #CCC19 #COVID19nCANCER COVID-19 and Cancer Consortium (CCC19) Registry

The evolution of the SARS-CoV-2 virus has presented ongoing challenges in the prevention and treatment of COVID-19, particularly since #omicron and its subvariants began to emerge. From CancerTherapyAdvisor. fal.cn/3xhaT #COVID19nCancer

Mike Thompson, MD, PhD, FASCO Keith Stockerl-Goldstein, MD 😷 Sam Rubinstein COVID-19 and Cancer Consortium (CCC19) Registry Blood Cancer Discovery This new research from Sam Rubinstein et al. is a critical reminder of the increased risk of severe COVID-19 for patients recently treated for B-lymphoid malignancies. It's essential that we continue to monitor the impact of #COVID19 nCancer #CCC19 #COVID19 #bmtsm #leusm #lymsm

📽️ New #JCO video abstract now available for #CancerScreening in the United States During the Second Year of the COVID-19 Pandemic by @Ahjemal et al

View here 👉 fal.cn/3xUtj #COVID19nCancer

What are the perspectives of patients with cancer in Nigeria 🇳🇬 on the impact of COVID-19 on tele-oncology❓ fal.cn/3xzI7 #GlobOnc #COVID19nCancer #telehealth #telemedicine

Patients with cancer continued to experience #COVID19 -related disruptions to their care in 2022, according to research presented at the National Comprehensive Cancer Network (NCCN) 2023 Annual Conference. fal.cn/3x657 #COVID19 nCancer

This qualitative study highlights pt experiences in the #COVID19 pandemic's early phase. These perspectives can help improve #cancercare delivery & mitigate impact on pts of a future public health crisis. Gladys M. Rodriguez, MD, MS Manali Patel MD ➡️ fal.cn/3yitc #COVID19 ncancer

Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] Sam Rubinstein et al. Mike Thompson, MD, PhD, FASCO COVID-19 and Cancer Consortium (CCC19) Registry Blood Cancer Discovery ow.ly/wC8F50IgpjR #COVID19 nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm

Low Neutralizing Antibody Responses Against SARS-CoV-2 in Elderly Myeloma Patients After the First BNT162b2 Vaccine Dose [Apr 16, 2021] Terpos et al. Blood Journal ow.ly/IP8150ErX8M #NCT04743388 #COVID19Vaccine #COVID19nCancer #CCC19 #geriheme #mmsm

The risk of in-hospital death from #COVID19 for patients with cancer differs by sex and cancer type. Published in JAMA Oncology. fal.cn/3xTVa #COVID19 nCancer #CancerCare

As we continue to share cancer survivor stories this month, read Lillian's story of battling anal cancer from our friends at HPV Cancer Alliances. Lillian is a co-founder of HPV Cancers Alliance.

analcancerfoundation.org/thriver-storie…

COVID-19 and cancer: A review of the registry-based pandemic response [Sep 2, 2021] Aakash Desai, MD, MPH Turab J Mohammed, MD et al. JAMA Oncology ow.ly/8fyz50G38Y4 #COVID19nCancer #CCC19 COVID-19 and Cancer Consortium (CCC19) Registry

Patients with #solidtumors do not appear to have an increased risk of side effects from #COVID19vaccination . Published in Journal of Clinical Oncology. fal.cn/3x4Dx #COVID19nCancer

#ASCODailyNews reports on a newly published #JCO study that sheds light on the number of delays in planned #cancerscreening during the #COVID19 pandemic: fal.cn/3vOuE #COVID19 nCancer #CancerPrevention

Weight stigma is common in society, but it can have especially damaging effects when the ideas seep into cancer care.

In 2020, 60% individuals had a planned #CancerScreening .

11-36% of them delayed the planned test due to #COVID19 🦠 fal.cn/3w4e6 Xiaochen Zhang Electra Paskett #COVID19 ncancer

#AntibodyTesting is effective for identifying patients with cancer who have low levels of protection against SARS-CoV-2, according to research published in JAMA Oncology and CancerTherapyAdvisor. fal.cn/3uWNF #COVID19nCancer

.Journal of Clinical Oncology study sheds light on the number of delays in planned #cancerscreening during the #COVID19 pandemic: fal.cn/3vM9g #ASCODailyNews #COVID19 nCancer #OncTwitter #MedTwitter

Breakthrough #COVID19 infections elicited greater humoral immune responses than the fourth dose of the BNT162b2 vaccine among patients with cancer. These findings were published in The Oncologist. fal.cn/3wRne #COVID19 nCancer

Characteristics of Patients with Hematologic Malignancies Without Seroconversion Post-COVID19 Third Vaccine Dosing [Feb 14, 2023] Hallmeyer et al. Biology Methods and Protocols academic.oup.com/cid/advance-ar… #COVID19Vaccine #COVID19nCancer #bmtsm #leusm #lymsm #mmsm #mpnsm #IDonc